Published in Biochimie on February 01, 1983
Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med (1996) 7.08
Persistence of memory CD8 T cells in MHC class I-deficient mice. Science (1999) 6.20
Identification and classification of bacterial plasmids. Microbiol Rev (1988) 4.16
Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. J Mol Biol (1992) 4.13
An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med (1999) 3.20
The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens. J Exp Med (1978) 2.20
Positive-selection vectors using the F plasmid ccdB killer gene. Gene (1994) 2.12
Lon-dependent proteolysis of CcdA is the key control for activation of CcdB in plasmid-free segregant bacteria. Mol Microbiol (1994) 2.02
The induction of cytolytic T lymphocytes with purified plasma membranes. J Immunol (1978) 1.80
The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase. J Mol Biol (1993) 1.68
Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob Agents Chemother (1994) 1.66
H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity. J Exp Med (1992) 1.64
ATP-dependent degradation of CcdA by Lon protease. Effects of secondary structure and heterologous subunit interactions. J Biol Chem (1996) 1.55
The induction of secondary cytolytic T lymphocytes by solubilized membrane proteins. J Exp Med (1978) 1.41
Interaction between the RP4 coupling protein TraG and the pBHR1 mobilization protein Mob. Mol Microbiol (2000) 1.40
The ratio between CcdA and CcdB modulates the transcriptional repression of the ccd poison-antidote system. Mol Microbiol (2001) 1.35
Crystal structure of CcdB, a topoisomerase poison from E. coli. J Mol Biol (1999) 1.35
High pleiotropy of streptomycin mutations in Escherichia coli. Biochem Biophys Res Commun (1964) 1.34
Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry (1997) 1.33
Mini-F encoded proteins: identification of a new 10.5 kilodalton species. EMBO J (1983) 1.29
Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta (1982) 1.24
Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus. Clin Chem Lab Med (1999) 1.24
Interactions of CcdB with DNA gyrase. Inactivation of Gyra, poisoning of the gyrase-DNA complex, and the antidote action of CcdA. J Biol Chem (1999) 1.23
Reduction of acetaminophen interference in glucose sensors by a composite Nafion membrane: demonstration in rats and man. Diabetologia (1994) 1.21
Isolation and location on the R27 map of two replicons and an incompatibility determinant specific for IncHI1 plasmids. J Bacteriol (1993) 1.20
Ham22, a mini-F mutation which is lethal to host cell and promotes recA-dependent induction of lambdoid prophage. EMBO J (1983) 1.19
Improved fluorometric determination of malonaldehyde. Clin Chem (1991) 1.15
The antidote and autoregulatory functions of the F plasmid CcdA protein: a genetic and biochemical survey. Mol Gen Genet (1994) 1.13
The interaction of the F plasmid killer protein, CcdB, with DNA gyrase: induction of DNA cleavage and blocking of transcription. J Mol Biol (1997) 1.12
F plasmid CcdB killer protein: ccdB gene mutants coding for non-cytotoxic proteins which retain their regulatory functions. Mol Microbiol (1995) 1.12
Cloning and characterization of the Inc A/C plasmid RA1 replicon. J Bacteriol (1994) 1.09
Prevalence of four enterotoxin (STaP, STaH, STb, and LT) and four adhesin subunit (K99, K88, 987P, and F41) genes among Escherichia coli isolates from cattle. Am J Vet Res (1990) 1.07
Use of a subcutaneous glucose sensor to detect decreases in glucose concentration prior to observation in blood. Anal Chem (1996) 1.07
Delineation of three subsets of class I human T antigens (HTA) on Molt-4 cells: serologic and regulatory relationship to HLA class I antigens. J Immunol (1985) 1.07
Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis. J Virol (2001) 1.05
Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem (1984) 1.03
Control of development in temperate bacteriophages. V. Sequential activation of the viral functions. Mol Gen Genet (1973) 1.02
Molecular analysis of the replication elements of the broad-host-range RepA/C replicon. Plasmid (1996) 1.02
A minor Q-independent pathway for the expression of the late genes in bacteriophage lambda. Mol Gen Genet (1971) 1.01
Mu-1 directed inhibition of DNA breakdown in Escherichia coli, recA cells. Mol Gen Genet (1978) 1.01
The 41 carboxy-terminal residues of the miniF plasmid CcdA protein are sufficient to antagonize the killer activity of the CcdB protein. Mol Gen Genet (1991) 1.01
Mobilization function of the pBHR1 plasmid, a derivative of the broad-host-range plasmid pBBR1. J Bacteriol (2001) 1.00
Effect of lactation in a mother with galactosemia. J Pediatr (1989) 0.98
Prolidase and prolidase deficiency. Life Sci (1984) 0.97
Progress toward the development of an implantable sensor for glucose. Clin Chem (1992) 0.97
Control of development in temperate bacteriophages. II. Control of lysozyme synthesis. J Mol Biol (1968) 0.97
Normal serum gamma-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis. J Pediatr (1987) 0.94
Molecular characterization of resistance plasmids in epidemiologically unrelated strains of multiresistant Haemophilus influenzae. J Infect Dis (1993) 0.92
[Phenotypic and genotypic properties of 4 virulence plasmids of Salmonella typhimurium]. Ann Inst Pasteur Microbiol (1988) 0.92
Diagnostic value of serum gamma-glutamyl transpeptidase activity in liver diseases in children. J Pediatr Gastroenterol Nutr (1991) 0.92
Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. J Clin Invest (1998) 0.90
Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C. Biochem Pharmacol (2006) 0.90
Retrotransfer or gene capture: a feature of conjugative plasmids, with ecological and evolutionary significance. Microbiology (1999) 0.90
Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome. Crit Care Med (1990) 0.89
Mu-1 promoted integration of a -gal phage in the chromosome of E. coli. Mol Gen Genet (1971) 0.89
Changes in prolinase and prolidase activity during CCl4 administration inducing liver cytolysis and fibrosis in rat. Br J Exp Pathol (1987) 0.88
Virulence factors produced by strains of Staphylococcus aureus isolated from urinary tract infections. J Hosp Infect (2007) 0.88
Nervous and ocular disorders in children with cholestasis and vitamin A and E deficiencies. Hepatology (1983) 0.88
Purification, circular dichroism analysis, crystallization and preliminary X-ray diffraction analysis of the F plasmid CcdB killer protein. J Mol Biol (1993) 0.88
Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope. Hepatology (2001) 0.87
Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. Arterioscler Thromb Vasc Biol (1999) 0.87
In vitro study of the cytotoxicity of isolated oxidized lipid low-density lipoproteins fractions in human endothelial cells: relationship with the glutathione status and cell morphology. Free Radic Biol Med (2000) 0.87
Association between novelty-seeking and the dopamine D3 receptor gene in bipolar patients: a preliminary report. Am J Med Genet (1998) 0.87
Construction in vitro of "phage-plasmid" chimerae: a new tool to analyse the mechanism of plasmid maintenance. Mol Gen Genet (1979) 0.87
[Application of derivative spectrophotometry in biochemistry]. Ann Biol Clin (Paris) (1985) 0.87
Mini-F E protein: the carboxy-terminal end is essential for E gene repression and mini-F copy number control. J Mol Biol (1986) 0.86
Determination of dipeptides in urine. Clin Chim Acta (1974) 0.86
Hybridization on bovine enterotoxigenic Escherichia coli with two heat-stable enterotoxin gene probes. Am J Vet Res (1985) 0.86
The integration and excision of the bacteriophage Mu-1. Cell (1976) 0.86
Hybrid genes between HLA-A2 and HLA-A3 constructed by in vivo recombination allow mapping of HLA-A2 and HLA-A3 polymorphic antigenic determinants. J Immunol (1988) 0.86
Rapid diagnosis of long chain and medium chain fatty acid oxidation disorders using lymphocytes. Ann Clin Biochem (1995) 0.86
Metronidazole kinetics in patients with acute renal failure on dialysis: a cumulative study. Clin Pharmacol Ther (1984) 0.85
Epidemiological study of Salmonella enteritidis strains of animal origin in Belgium. Epidemiol Infect (1991) 0.84
Replicon typing of 71 multiresistant Serratia marcescens strains. Res Microbiol (1994) 0.84
Determination of plasma lipoperoxides by high-performance liquid chromatography. J Chromatogr (1987) 0.84
Amino acid transport systems in the human hepatoma cell line Hep G2. Biochem Biophys Res Commun (1992) 0.84
Risk factors and treatment of stroke at the time of recurrence. Acta Neurol Belg (2010) 0.84
[Lipoprotein lipase activity in human milk; inhibition in vitro of the glucuro-conjugation of bilirubin (author's transl)]. Clin Chim Acta (1975) 0.84
Replicon typing of virulence plasmids of enterotoxigenic Escherichia coli isolates from cattle. Infect Immun (1992) 0.83
Vegetative recombination in bacteriophage Mu-1. Virology (1974) 0.83
Nucleotide sequence and replication characteristics of RepHI1B: a replicon specific to the IncHI1 plasmids. Plasmid (1994) 0.83
Faster estimation of reserve bilirubin binding capacity of serum from the neonate by thin-layer chromatography on sephadex. Clin Chem (1977) 0.83
Inhibition of the induction of cytolytic T lymphocytes with alloantisera directed against H-2K and H-2D gene products. J Immunol (1978) 0.83
Isolation and characterization of an abnormal alpha slow-moving high-density lipoprotein subfraction in serum from children with long-standing cholestasis. Clin Chem (1986) 0.82
Defective galactose oxidation in a patient with glycogen storage disease and Fanconi syndrome. Pediatr Res (1983) 0.82
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors. Eur J Immunol (2001) 0.82
Plasma prolidase and prolinase activity in alcoholic liver disease. Clin Chim Acta (1988) 0.82
[The intermittent variant of leucinosis (study of a new case)]. Arch Fr Pediatr (1971) 0.82
Direct selection cloning vectors adapted to the genetic analysis of gram-negative bacteria and their plasmids. Gene (1998) 0.82
Cell density affects prolidase and prolinase activity and intracellular amino acid levels in cultured human cells. Clin Chim Acta (1985) 0.82
Assessment of beta-adrenergic blockade with propranolol in patients with cirrhosis. Hepatology (1984) 0.81
Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience. Clin Biochem (1991) 0.81
V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. J Immunol (2000) 0.81
Lens hexitols and cataract formation during lactation in a woman heterozygote for galactosaemia. J Inherit Metab Dis (1989) 0.81
[Biological and physiopathological aspects of hepatic glycogenoses]. Ann Gastroenterol Hepatol (Paris) (1988) 0.80
[Study of the metabolism of tryptophane in various hepato-intestinal diseases. II. Frequency of anomalies in neoplastic diseases]. Rev Fr Etud Clin Biol (1967) 0.80
Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination. Eur J Clin Pharmacol (1983) 0.80
Inhibition by Fab and Fab'2 monoclonal anti-Ia antibody fragments of T-lymphocyte proliferative responses. Immunology (1982) 0.80